1SB
IBB icon

1ST Source Bank’s iShares Biotechnology ETF IBB Stock Holding History

1ST Source Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
13,311
-501
-4% -$86.1K 0.11% 96
2026
Q1 		$2.33M Sell
13,812
-383
-3% -$65.5K 0.12% 88
2025
Q4 		$2.4M Buy
14,195
+324
+2% +$52.6K 0.13% 88
2025
Q3 		$2M Sell
13,871
-73
-0.5% -$9.96K 0.11% 98
2025
Q2 		$1.76M Sell
13,944
-717
-5% -$88K 0.1% 101
2025
Q1 		$1.88M Sell
14,661
-281
-2% -$38.1K 0.11% 92
2024
Q4 		$1.98M Sell
14,942
-835
-5% -$117K 0.11% 94
2024
Q3 		$2.3M Sell
15,777
-398
-2% -$57.6K 0.13% 91
2024
Q2 		$2.22M Sell
16,175
-73
-0.4% -$9.74K 0.13% 91
2024
Q1 		$2.23M Buy
16,248
+43
+0.3% +$5.87K 0.13% 88
2023
Q4 		$2.2M Sell
16,205
-670
-4% -$81.7K 0.13% 87
2023
Q3 		$2.06M Sell
16,875
-681
-4% -$86.6K 0.14% 85
2023
Q2 		$2.23M Sell
17,556
-576
-3% -$74.8K 0.14% 90
2023
Q1 		$2.34M Sell
18,132
-228
-1% -$29.8K 0.16% 85
2022
Q4 		$2.41M Sell
18,360
-386
-2% -$49.9K 0.16% 81
2022
Q3 		$2.19M Sell
18,746
-30
-0.2% -$3.73K 0.16% 84
2022
Q2 		$2.21M Sell
18,776
-931
-5% -$111K 0.16% 82
2022
Q1 		$2.57M Buy
19,707
+295
+2% +$38.4K 0.16% 78
2021
Q4 		$2.96M Buy
19,412
+54
+0.3% +$8.36K 0.17% 74
2021
Q3 		$3.13M Sell
19,358
-139
-0.7% -$23.4K 0.2% 69
2021
Q2 		$3.19M Buy
19,497
+78
+0.4% +$12K 0.2% 67
2021
Q1 		$2.92M Sell
19,419
-302
-2% -$48K 0.19% 64
2020
Q4 		$2.99M Buy
19,721
+54
+0.3% +$7.72K 0.22% 63
2020
Q3 		$2.66M Sell
19,667
-276
-1% -$37.4K 0.23% 70
2020
Q2 		$2.73M Buy
19,943
+264
+1% +$33.7K 0.23% 65
2020
Q1 		$2.12M Buy
19,679
+138
+0.7% +$15.9K 0.21% 70
2019
Q4 		$2.35M Buy
19,541
+68
+0.3% +$7.59K 0.18% 75
2019
Q3 		$1.94M Sell
19,473
-457
-2% -$47.8K 0.16% 80
2019
Q2 		$2.17M Sell
19,930
-7,480
-27% -$796K 0.18% 78
2019
Q1 		$3.06M Buy
27,410
+436
+2% +$47.8K 0.26% 59
2018
Q4 		$2.6M Sell
26,974
-5,258
-16% -$558K 0.25% 64
2018
Q3 		$3.93M Sell
32,232
-1,799
-5% -$212K 0.31% 53
2018
Q2 		$3.74M Sell
34,031
-75
-0.2% -$8.02K 0.3% 50
2018
Q1 		$3.64M Buy
34,106
+3,011
+10% +$334K 0.3% 53
2017
Q4 		$3.32M Buy
31,095
+4,716
+18% +$504K 0.27% 57
2017
Q3 		$2.93M Buy
26,379
+1,494
+6% +$160K 0.24% 60
2017
Q2 		$2.57M Buy
24,885
+240
+1% +$23.6K 0.22% 68
2017
Q1 		$2.41M Sell
24,645
-1,149
-4% -$110K 0.21% 68
2016
Q4 		$2.28M Sell
25,794
-9,666
-27% -$880K 0.22% 66
2016
Q3 		$3.42M Buy
35,460
+1,134
+3% +$108K 0.36% 50
2016
Q2 		$2.94M Buy
34,326
+24
+0.1% +$2.15K 0.33% 56
2016
Q1 		$2.98M Buy
34,302
+615
+2% +$55K 0.33% 57
2015
Q4 		$3.8M Sell
33,687
-12,603
-27% -$1.37M 0.44% 49
2015
Q3 		$4.68M Buy
46,290
+6,507
+16% +$780K 0.54% 37
2015
Q2 		$4.89M Buy
39,783
+12,369
+45% +$1.48M 0.53% 37
2015
Q1 		$3.14M Buy
27,414
+8,466
+45% +$934K 0.38% 56
2014
Q4 		$1.92M Buy
18,948
+7,416
+64% +$721K 0.23% 74
2014
Q3 		$1.05M Sell
11,532
-198
-2% -$17.4K 0.14% 101
2014
Q2 		$1M Sell
11,730
-225
-2% -$17.7K 0.13% 106
2014
Q1 		$942K Buy
11,955
+8,250
+223% +$687K 0.13% 109
2013
Q4 		$280K Hold
3,705
– – 0.04% 179
2013
Q3 		$259K Hold
3,705
– – 0.04% 190
2013
Q2 		$215K Buy
+3,705
New +$214K 0.04% 186

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

1ST Source Bank's IBB Position: Q2 2026 in Review

1ST Source Bank reduced its iShares Biotechnology ETF (IBB) stake by 3.6% in Q2 2026, selling an estimated $86.1K and leaving 13,311 shares worth $2.53M. The position accounts for 0.11% of the portfolio, ranked #96.

1ST Source Bank first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.89M in Q2 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • 1ST Source Bank held 13,311 shares of iShares Biotechnology ETF worth $2.53M as of Q2 2026.
  • 1ST Source Bank sold 501 iShares Biotechnology ETF shares in Q2 2026, an estimated $86.1K.
  • iShares Biotechnology ETF made up 0.11% of 1ST Source Bank's portfolio in Q2 2026, its #96 holding.
  • 1ST Source Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • 1ST Source Bank's iShares Biotechnology ETF position peaked at $4.89M in Q2 2015.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on 1ST Source Bank's 13F filing for Q2 2026, filed 6 Aug 2026.